Levothyroxine product-specific bioequivalence guidance
Submitted by Anonymous (not verified) on 1 July 2025 - 11:55
Levothyroxine product-specific bioequivalence guidance
Human medicines European public assessment report (EPAR): Synjardy, empagliflozin,metformin, Date of authorisation: 27/05/2015, Revision: 31, Status: Authorised
Submitted by Anonymous (not verified) on 1 July 2025 - 11:41
Human medicines European public assessment report (EPAR): Synjardy, empagliflozin,metformin, Date of authorisation: 27/05/2015, Revision: 31, Status: Authorised
Medicinal Product master data for better regulation and better health - Network Data Steering Group (NDSG) recommendations for human Product Master Data implementation and data management
Submitted by Anonymous (not verified) on 1 July 2025 - 11:02
Medicinal Product master data for better regulation and better health - Network Data Steering Group (NDSG) recommendations for human Product Master Data implementation and data management
Annual accounts: Financial year 2024
Submitted by Anonymous (not verified) on 1 July 2025 - 10:28
Annual accounts: Financial year 2024
Declaration on the qualification of an enterprise as a micro, small or medium-sized enterprise (SME)
Submitted by Anonymous (not verified) on 1 July 2025 - 10:18
Declaration on the qualification of an enterprise as a micro, small or medium-sized enterprise (SME)
Human medicines European public assessment report (EPAR): Sorafenib Accord, sorafenib, Date of authorisation: 09/11/2022, Revision: 3, Status: Authorised
Submitted by Anonymous (not verified) on 1 July 2025 - 10:08
Human medicines European public assessment report (EPAR): Sorafenib Accord, sorafenib, Date of authorisation: 09/11/2022, Revision: 3, Status: Authorised
Human medicines European public assessment report (EPAR): Columvi, glofitamab, Date of authorisation: 07/07/2023, Revision: 5, Status: Authorised
Submitted by Anonymous (not verified) on 1 July 2025 - 8:10
Human medicines European public assessment report (EPAR): Columvi, glofitamab, Date of authorisation: 07/07/2023, Revision: 5, Status: Authorised
Ethical use of animals in medicine testing
Submitted by Anonymous (not verified) on 1 July 2025 - 8:00
Ethical use of animals in medicine testing
Transparency: exceptional measures for COVID-19 medicines
Submitted by Anonymous (not verified) on 30 June 2025 - 16:00
Transparency: exceptional measures for COVID-19 medicines
Human medicines European public assessment report (EPAR): Jardiance, empagliflozin, Date of authorisation: 22/05/2014, Revision: 32, Status: Authorised
Submitted by Anonymous (not verified) on 30 June 2025 - 15:29
Human medicines European public assessment report (EPAR): Jardiance, empagliflozin, Date of authorisation: 22/05/2014, Revision: 32, Status: Authorised